Abstract
BackgroundHyperactivity related behaviors as well as inattention and impulsivity are regarded as the nuclear symptoms of attention-deficit/hyperactivity disorder (ADHD).PurposeTo investigate the therapeutic effects of atomoxetine on the motor activity in relation to the expression of the dopamine (DA) D2 receptor based on the hypothesis that DA system hypofunction causes ADHD symptoms, which would correlate with extensive D2 receptor overproduction and a lack of DA synthesis in specific brain regions: prefrontal cortex (PFC), striatum, and hypothalamus.MethodsYoung male spontaneously hypertensive rats (SHR), animal models of ADHD, were randomly divided into four groups according to the daily dosage of atomoxetine and treated for 21 consecutive days. The animals were assessed using an open-field test, and the DA D2 receptor expression was examined.ResultsThe motor activity improved continuously in the group treated with atomoxetine at a dose of 1 mg/Kg/day than in the groups treated with atomoxetine at a dose of 0.25 mg/Kg/day or 0.5 mg/Kg/day. With respect to DA D2 receptor immunohistochemistry, we observed significantly increased DA D2 receptor expression in the PFC, striatum, and hypothalamus of the SHRs as compared to the WKY rats. Treatment with atomoxetine significantly decreased DA D2 expression in the PFC, striatum, and hypothalamus of the SHRs, in a dose-dependent manner.ConclusionHyperactivity in young SHRs can be improved by treatment with atomoxetine via the DA D2 pathway.
Highlights
Attention-deficit/hyperactivity disorder (ADHD) is a common childhood and adolescent disorder that affects 5–10% of schoolaged children worldwide [1] and can affect 3–5% of the adult population [2]
The ‘‘dopaminergic hypothesis’’ is the most widely accepted hypothesis by researchers for understanding the attention-deficit/hyperactivity disorder (ADHD) pathophysiology [3]. It is based on dysregulation in dopaminergic neurotransmission causing behavioral alterations in both ADHD and in the spontaneously hypertensive rat (SHR), which has been used as an ADHD animal model [4]
We investigated the therapeutic effects of atomoxetine on the motor activity in relation to the expression of the DA D2 receptor in the SHR animal model of ADHD based on the hypothesis that DA system hypofunction causes ADHD symptoms, which would correlate with extensive D2 receptor overproduction and a lack of DA synthesis in specific brain regions such as prefrontal cortex (PFC), striatum, and hypothalamus
Summary
Attention-deficit/hyperactivity disorder (ADHD) is a common childhood and adolescent disorder that affects 5–10% of schoolaged children worldwide [1] and can affect 3–5% of the adult population [2]. The ‘‘dopaminergic hypothesis’’ is the most widely accepted hypothesis by researchers for understanding the ADHD pathophysiology [3] It is based on dysregulation in dopaminergic neurotransmission causing behavioral alterations in both ADHD and in the spontaneously hypertensive rat (SHR), which has been used as an ADHD animal model [4]. Initial functional MRI studies showed decreased activation of the dopamine (DA) pathway [5] and the DA hypothesis suggested that DA deficits in specific brain regions, such as cortical areas and/or the striatum, could produce ADHD symptoms [6]. Purpose: To investigate the therapeutic effects of atomoxetine on the motor activity in relation to the expression of the dopamine (DA) D2 receptor based on the hypothesis that DA system hypofunction causes ADHD symptoms, which would correlate with extensive D2 receptor overproduction and a lack of DA synthesis in specific brain regions: prefrontal cortex (PFC), striatum, and hypothalamus
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.